The field of diabetes treatment is undergoing a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide stand out as potential game-changers. These of https://aronrwje517414.iyublog.com/37890016/novel-glp-1-receptor-agonists-retatrutide-and-trizepatide